CA2164332A1 - Methods of removing radioactively labeled biological molecules from liquid radioactive waste - Google Patents
Methods of removing radioactively labeled biological molecules from liquid radioactive wasteInfo
- Publication number
- CA2164332A1 CA2164332A1 CA002164332A CA2164332A CA2164332A1 CA 2164332 A1 CA2164332 A1 CA 2164332A1 CA 002164332 A CA002164332 A CA 002164332A CA 2164332 A CA2164332 A CA 2164332A CA 2164332 A1 CA2164332 A1 CA 2164332A1
- Authority
- CA
- Canada
- Prior art keywords
- binder
- solid phase
- radioactively labeled
- radioactive waste
- magnetizable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000010857 liquid radioactive waste Substances 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims description 101
- 239000011230 binding agent Substances 0.000 claims abstract description 124
- 239000007790 solid phase Substances 0.000 claims abstract description 109
- 239000002245 particle Substances 0.000 claims description 84
- 239000003463 adsorbent Substances 0.000 claims description 55
- 239000003610 charcoal Substances 0.000 claims description 37
- 230000000984 immunochemical effect Effects 0.000 claims description 34
- 239000002901 radioactive waste Substances 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 24
- 239000007791 liquid phase Substances 0.000 claims description 13
- 229920002401 polyacrylamide Polymers 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000001913 cellulose Substances 0.000 claims description 11
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 9
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 claims description 9
- 239000011324 bead Substances 0.000 claims description 8
- 229940014144 folate Drugs 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 claims description 7
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011521 glass Substances 0.000 claims description 7
- 229940034208 thyroxine Drugs 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 235000019163 vitamin B12 Nutrition 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000005291 magnetic effect Effects 0.000 claims description 5
- 239000011491 glass wool Substances 0.000 claims description 4
- 239000002952 polymeric resin Substances 0.000 claims description 4
- 229920003002 synthetic resin Polymers 0.000 claims description 4
- 239000000454 talc Substances 0.000 claims description 4
- 229910052623 talc Inorganic materials 0.000 claims description 4
- 238000012545 processing Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 62
- 239000000463 material Substances 0.000 description 27
- 238000003127 radioimmunoassay Methods 0.000 description 22
- 239000000427 antigen Substances 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 230000002285 radioactive effect Effects 0.000 description 14
- 239000011347 resin Substances 0.000 description 14
- 229920005989 resin Polymers 0.000 description 14
- 238000000926 separation method Methods 0.000 description 12
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 238000003556 assay Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000470 constituent Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 230000005484 gravity Effects 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 239000006193 liquid solution Substances 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- -1 polyacrolein Polymers 0.000 description 5
- 239000005373 porous glass Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000000155 isotopic effect Effects 0.000 description 3
- 239000010808 liquid waste Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000012857 radioactive material Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000283986 Lepus Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 241000473945 Theria <moth genus> Species 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000010936 aqueous wash Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 101000689231 Aeromonas salmonicida S-layer protein Proteins 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- 241000518994 Conta Species 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000069444 Tetrameres Species 0.000 description 1
- 101000748795 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Cytochrome c oxidase polypeptide I+III Proteins 0.000 description 1
- 101710123661 Venom allergen 5 Proteins 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000002925 low-level radioactive waste Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 229910000480 nickel oxide Inorganic materials 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- AJCDFVKYMIUXCR-UHFFFAOYSA-N oxobarium;oxo(oxoferriooxy)iron Chemical compound [Ba]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O AJCDFVKYMIUXCR-UHFFFAOYSA-N 0.000 description 1
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002594 sorbent Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21F—PROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
- G21F9/00—Treating radioactively contaminated material; Decontamination arrangements therefor
- G21F9/04—Treating liquids
- G21F9/06—Processing
- G21F9/12—Processing by absorption; by adsorption; by ion-exchange
Landscapes
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7303993A | 1993-06-08 | 1993-06-08 | |
| US08/073,039 | 1994-06-07 | ||
| US08/255,229 US5564104A (en) | 1993-06-08 | 1994-06-07 | Methods of removing radioactively labled biological molecules from liquid radioactive waste |
| US08/255,229 | 1994-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2164332A1 true CA2164332A1 (en) | 1994-12-22 |
Family
ID=26754056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002164332A Abandoned CA2164332A1 (en) | 1993-06-08 | 1994-06-08 | Methods of removing radioactively labeled biological molecules from liquid radioactive waste |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US5564104A (OSRAM) |
| EP (2) | EP0932163A3 (OSRAM) |
| JP (1) | JPH09500446A (OSRAM) |
| AU (1) | AU7058594A (OSRAM) |
| CA (1) | CA2164332A1 (OSRAM) |
| WO (1) | WO1994029880A1 (OSRAM) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115109939A (zh) * | 2022-07-11 | 2022-09-27 | 上海交通大学四川研究院 | 一种低放射性本底金属材料的冶炼方法 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103127A (en) | 1993-06-08 | 2000-08-15 | Cortex Biochem, Inc. | Methods for removing hazardous organic molecules from liquid waste |
| US5827497A (en) * | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| US6199152B1 (en) | 1996-08-22 | 2001-03-06 | Transmeta Corporation | Translated memory protection apparatus for an advanced microprocessor |
| US6368866B1 (en) | 1998-08-03 | 2002-04-09 | Reference Diagnostics, Inc. | Rapid separation assay for total iron binding capacity |
| IES990347A2 (en) * | 1999-04-26 | 2000-10-04 | Suren Aghajanian | De-staining Composition and Apparatus |
| KR100330040B1 (ko) * | 1999-04-30 | 2002-03-27 | 정신검 | 액체 방사물 여과장치 및 그 방법 |
| US6414136B1 (en) | 1999-10-06 | 2002-07-02 | Prolinx, Inc. | Removal of dye-labeled dideoxy terminators from DNA sequencing reactions |
| US6968469B1 (en) | 2000-06-16 | 2005-11-22 | Transmeta Corporation | System and method for preserving internal processor context when the processor is powered down and restoring the internal processor context when processor is restored |
| US6855499B1 (en) | 2001-02-16 | 2005-02-15 | Cortex Biochem, Inc. | Magnetic isolation and purification of nucleic acids |
| WO2003015871A2 (en) * | 2001-07-25 | 2003-02-27 | University Of North Carolina At Chapel Hill | Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| US20040137449A1 (en) * | 2001-10-05 | 2004-07-15 | Nargessi R D | Magnetic isolation and purification of nucleic acids |
| JP4277115B2 (ja) * | 2001-11-06 | 2009-06-10 | プロメガ・コーポレーション | 核酸の単離および精製 |
| GB0212850D0 (en) * | 2002-06-01 | 2002-07-17 | Accentus Plc | New recovery process |
| US6972095B1 (en) | 2003-05-07 | 2005-12-06 | Electric Power Research Institute | Magnetic molecules: a process utilizing functionalized magnetic ferritins for the selective removal of contaminants from solution by magnetic filtration |
| US20050158812A1 (en) * | 2004-01-16 | 2005-07-21 | Gomez Elizabeth A. | Kits and methods for autoantibody detection |
| JP3927580B2 (ja) * | 2004-12-09 | 2007-06-13 | 住友ベークライト株式会社 | Ｄｎａ鎖伸長方法、ｄｎａ鎖増幅方法およびｄｎａ鎖伸長用マイクロアレイ |
| US8822670B2 (en) * | 2005-08-19 | 2014-09-02 | Sumitomo Bakelite Company, Ltd. | Method of synthesizing cDNA and method of synthesizing RNA chains, and nucleotide-immobilized carrier |
| US8097164B2 (en) * | 2007-11-08 | 2012-01-17 | Electric Power Research Institute, Inc. | Process for preparing magnetic particles for selectively removing contaminants from solution |
| US8039613B2 (en) | 2009-08-28 | 2011-10-18 | Promega Corporation | Methods of purifying a nucleic acid and formulation and kit for use in performing such methods |
| US8222397B2 (en) | 2009-08-28 | 2012-07-17 | Promega Corporation | Methods of optimal purification of nucleic acids and kit for use in performing such methods |
| US9240253B2 (en) * | 2010-04-07 | 2016-01-19 | Ge-Hitachi Nuclear Energy Americas Llc | Column geometry to maximize elution efficiencies for molybdenum-99 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2752309A (en) * | 1952-04-30 | 1956-06-26 | Ardath H Emmons | Process for water decontamination |
| US4213825A (en) * | 1976-08-23 | 1980-07-22 | Rolf Saxholm | Apparatus for testing reactions |
| US4371624A (en) * | 1976-08-23 | 1983-02-01 | Rolf Saxholm | Apparatus and testing reactions |
| US3981776A (en) * | 1967-02-16 | 1976-09-21 | Rolf Saxholm | Magnetically responsive, biologically active substance and associated methods and apparatus |
| FR1573936A (OSRAM) * | 1967-02-16 | 1969-07-11 | ||
| US4992377B1 (en) * | 1967-02-16 | 1996-10-15 | Saxholm As | Article for carrying out biological or chemical procedures containing magnetically responsive material |
| US3985608A (en) * | 1969-05-03 | 1976-10-12 | Rolf Saxholm | Supporting element for use in microbiological, serological, immunological, clinical-chemical and similar laboratory work |
| NO124603B (OSRAM) * | 1969-05-03 | 1972-05-08 | Rolf Saxholm | |
| US4140582A (en) * | 1969-05-03 | 1979-02-20 | Rolf Saxholm | Supporting element for use in microbiological, serological, immunological clinical-chemical and similar laboratory work |
| US4033868A (en) * | 1970-07-20 | 1977-07-05 | Licentia Patent-Verwaltungs-G.M.B.H. | Method and apparatus for processing contaminated wash water |
| US3902849A (en) * | 1971-08-19 | 1975-09-02 | Medi Physics Inc | Radioisotope and radiopharmaceutical generators |
| US3986479A (en) * | 1973-10-11 | 1976-10-19 | Colgate-Palmolive Company | Pre-moistened towelette dispenser |
| US4020003A (en) * | 1976-02-24 | 1977-04-26 | The United States Of America As Represented By The United States Energy Research And Development Administration | Fixation of tritium in a highly stable polymer form |
| US4104026A (en) * | 1976-03-12 | 1978-08-01 | University Of Virginia | Immunoassay separation technique |
| US4657868A (en) * | 1980-01-15 | 1987-04-14 | Rolf Saxholm | Apparatus for testing reactions |
| US4695392A (en) * | 1983-05-12 | 1987-09-22 | Advanced Magnetics Inc. | Magnetic particles for use in separations |
| JPS59231493A (ja) * | 1983-06-15 | 1984-12-26 | 住友金属鉱山株式会社 | 低レベル放射性廃液の処理方法 |
| US4643981A (en) * | 1983-11-09 | 1987-02-17 | Akzo N.V. | Pressure filtration system |
| US4687581A (en) * | 1984-01-30 | 1987-08-18 | Pedro B. Macedo | Method of separating and purifying cations by ion exchange with regenerable porous glass |
| US4645625A (en) * | 1984-11-26 | 1987-02-24 | Ionics, Incorporated | Decontamination of a radioactive waste liquid by electrodialysis |
| US4800042A (en) * | 1985-01-22 | 1989-01-24 | Jgc Corporation | Radioactive waste water treatment |
| US4853130A (en) * | 1985-12-20 | 1989-08-01 | Epicor Incorporated | Method for purifying liquids |
| US4902665A (en) * | 1986-04-07 | 1990-02-20 | Iso-Clear Systems Corporation | Removal of heavy metals and heavy metal radioactive isotopes from liquids |
| US4780239A (en) * | 1986-05-22 | 1988-10-25 | Westinghouse Electric Corp. | Ion exchange resin for immobilizing radioactive waste |
| GB8719045D0 (en) * | 1987-08-12 | 1987-10-07 | Atomic Energy Authority Uk | Liquid treatment process |
| US4876232A (en) * | 1987-09-28 | 1989-10-24 | Pedro B. Macedo | Supported heteropolycyclic compounds in the separation and removal of late transition metals |
| US5024767A (en) * | 1988-04-04 | 1991-06-18 | Toray Industries, Inc. | Method for purifying liquids |
| DD293219A5 (de) * | 1988-12-14 | 1991-08-22 | ������@������������k�� | Verfahren zum aufbereiten von borverbindungen und radionuklide enthaltendem abwasser |
| US5122268A (en) * | 1989-08-11 | 1992-06-16 | Westinghouse Electric Corp. | Apparatus for waste disposal of radioactive hazardous waste |
-
1994
- 1994-06-07 US US08/255,229 patent/US5564104A/en not_active Expired - Lifetime
- 1994-06-08 WO PCT/US1994/006521 patent/WO1994029880A1/en not_active Ceased
- 1994-06-08 EP EP98122702A patent/EP0932163A3/en not_active Withdrawn
- 1994-06-08 CA CA002164332A patent/CA2164332A1/en not_active Abandoned
- 1994-06-08 JP JP7502104A patent/JPH09500446A/ja active Pending
- 1994-06-08 AU AU70585/94A patent/AU7058594A/en not_active Abandoned
- 1994-06-08 EP EP94919432A patent/EP0788651A1/en not_active Withdrawn
-
1996
- 1996-05-31 US US08/657,748 patent/US5790964A/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115109939A (zh) * | 2022-07-11 | 2022-09-27 | 上海交通大学四川研究院 | 一种低放射性本底金属材料的冶炼方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US5564104A (en) | 1996-10-08 |
| EP0932163A2 (en) | 1999-07-28 |
| EP0932163A3 (en) | 1999-08-04 |
| WO1994029880A1 (en) | 1994-12-22 |
| AU7058594A (en) | 1995-01-03 |
| US5790964A (en) | 1998-08-04 |
| EP0788651A4 (OSRAM) | 1997-08-13 |
| JPH09500446A (ja) | 1997-01-14 |
| EP0788651A1 (en) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5790964A (en) | Methods of removing radioactively labeled biological molecules from liquid radioactive waste | |
| US6103127A (en) | Methods for removing hazardous organic molecules from liquid waste | |
| CA1226215A (en) | Immunoassay of antigens | |
| US4059685A (en) | Immobilized immunoadsorbent | |
| US4180383A (en) | Chamber holder for immobilized immunoadsorbent | |
| US3442819A (en) | Molecular sieve coated particulate adsorbent and processes using same | |
| US4338094A (en) | Macroencapsulated immunosorbent assay technique | |
| US4166102A (en) | Immobilized immunoadsorbent | |
| US5336760A (en) | Method and useful apparatus for preparing pharmaceutical compositions | |
| JPH0445785B2 (OSRAM) | ||
| WO1999062073A1 (en) | Method for sequential injection of liquid samples for radioisotope separations | |
| DK147809B (da) | Immobiliseret immunoadsorbent | |
| CA1118364A (en) | Charcoal coated absorbent device | |
| US5206346A (en) | Method for iodination/purification | |
| Holmskov-Nielsen et al. | Immune complex formation analysed by high-performance size exclusion chromatography (HPLC-SEC) using either 125I-labelled antigen or enzyme-linked immunosorbent assay (ELISA) for detection | |
| EP0007744B1 (en) | Assay for thyroid hormone binding capacity | |
| Boche et al. | Adsorption to glass and specific antibody inhibition of iodine125 labeled influenza virus | |
| Nustad et al. | Monosized Polymer Particles in Immunoassays: Applications and Immunochemistry | |
| US4394391A (en) | Radioimmunoassay reagents | |
| DeBarI et al. | Differential immunoadsorption coupled with rate nephelometry for estimation of DNA-binding immunoglobulins. | |
| CA1083934A (en) | Chamber holder for an immobilized immunoadsorbent | |
| Parkinson et al. | Rapid preparation and purification of alkaline phosphatase and 125I-labeled antibody by minicolumn gel centrifugation chromatography | |
| Ellickson | The bioaccessibility of selected radionuclides and heavy metals: An investigation of bioaccessibility, bioavailability and natural soil characteristics | |
| Rogers et al. | Automation of Radioimmunoassay | |
| Tang | Post-HPLC immunoreaction detection coupled on-line with a laboratory-constructed magnetic separation flow chamber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |